Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
editorial
. 1994 May;96(2):179–181. doi: 10.1111/j.1365-2249.1994.tb06538.x

Do T cells cause HTLV-1-associated disease?: a taxing problem.

S Daenke, C R Bangham
PMCID: PMC1534872  PMID: 8187324

Full text

PDF
179

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Althage A., Odermatt B., Moskophidis D., Kündig T., Hoffman-Rohrer U., Hengartner H., Zinkernagel R. M. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol. 1992 Jul;22(7):1803–1812. doi: 10.1002/eji.1830220720. [DOI] [PubMed] [Google Scholar]
  2. Berneman Z. N., Gartenhaus R. B., Reitz M. S., Jr, Blattner W. A., Manns A., Hanchard B., Ikehara O., Gallo R. C., Klotman M. E. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3005–3009. doi: 10.1073/pnas.89.7.3005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chen Y. M., Okayama A., Lee T. H., Tachibana N., Mueller N., Essex M. Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1182–1186. doi: 10.1073/pnas.88.4.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Elovaara I., Koenig S., Brewah A. Y., Woods R. M., Lehky T., Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993 Jun 1;177(6):1567–1573. doi: 10.1084/jem.177.6.1567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Green J. E., Hinrichs S. H., Vogel J., Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV-1 tax transgenic mice. Nature. 1989 Sep 7;341(6237):72–74. doi: 10.1038/341072a0. [DOI] [PubMed] [Google Scholar]
  6. Higashiyama Y., Katamine S., Kohno S., Mukae H., Hino S., Miyamoto T., Hara K. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals. Clin Exp Immunol. 1994 May;96(2):193–201. doi: 10.1111/j.1365-2249.1994.tb06541.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajima I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 1991 Aug 30;253(5023):1026–1028. doi: 10.1126/science.1887217. [DOI] [PubMed] [Google Scholar]
  8. Iwasaki Y., Ohara Y., Kobayashi I., Akizuki S. Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am J Pathol. 1992 May;140(5):1003–1008. [PMC free article] [PubMed] [Google Scholar]
  9. Kinoshita T., Shimoyama M., Tobinai K., Ito M., Ito S., Ikeda S., Tajima K., Shimotohno K., Sugimura T. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5620–5624. doi: 10.1073/pnas.86.14.5620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kira J., Itoyama Y., Koyanagi Y., Tateishi J., Kishikawa M., Akizuki S., Kobayashi I., Toki N., Sueishi K., Sato H. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol. 1992 Jan;31(1):39–45. doi: 10.1002/ana.410310108. [DOI] [PubMed] [Google Scholar]
  11. Koenig S., Woods R. M., Brewah Y. A., Newell A. J., Jones G. M., Boone E., Adelsberger J. W., Baseler M. W., Robinson S. M., Jacobson S. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease. J Immunol. 1993 Oct 1;151(7):3874–3883. [PubMed] [Google Scholar]
  12. Lal R. B., Rudolph D., Buckner C., Pardi D., Hooper W. C. Infection with human T-lymphotropic viruses leads to constitutive expression of leukemia inhibitory factor and interleukin-6. Blood. 1993 Apr 1;81(7):1827–1832. [PubMed] [Google Scholar]
  13. Murphy E. L., Hanchard B., Figueroa J. P., Gibbs W. N., Lofters W. S., Campbell M., Goedert J. J., Blattner W. A. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989 Feb 15;43(2):250–253. doi: 10.1002/ijc.2910430214. [DOI] [PubMed] [Google Scholar]
  14. Nishioka K., Nakajima T., Hasunuma T., Sato K. Rheumatic manifestation of human leukemia virus infection. Rheum Dis Clin North Am. 1993 May;19(2):489–503. [PubMed] [Google Scholar]
  15. Parker C. E., Daenke S., Nightingale S., Bangham C. R. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology. 1992 Jun;188(2):628–636. doi: 10.1016/0042-6822(92)90517-s. [DOI] [PubMed] [Google Scholar]
  16. Phillips R. E., Rowland-Jones S., Nixon D. F., Gotch F. M., Edwards J. P., Ogunlesi A. O., Elvin J. G., Rothbard J. A., Bangham C. R., Rizza C. R. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991 Dec 12;354(6353):453–459. doi: 10.1038/354453a0. [DOI] [PubMed] [Google Scholar]
  17. Sawada M., Suzumura A., Kondo N., Marunouchi T. Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I. FEBS Lett. 1992 Nov 16;313(1):47–50. doi: 10.1016/0014-5793(92)81181-k. [DOI] [PubMed] [Google Scholar]
  18. Verdier M., Bonis J., Leonard G., Dumas M., Denis F. HTLV-1 antibody class and subclass distribution in African TSP and control populations. J Neuroimmunol. 1993 Jan;42(1):117–120. doi: 10.1016/0165-5728(93)90219-o. [DOI] [PubMed] [Google Scholar]
  19. Wolin M., Kornuc M., Hong C., Shin S. K., Lee F., Lau R., Nimer S. Differential effect of HTLV infection and HTLV Tax on interleukin 3 expression. Oncogene. 1993 Jul;8(7):1905–1911. [PubMed] [Google Scholar]
  20. Yodoi J., Uchiyama T. Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today. 1992 Oct;13(10):405–411. doi: 10.1016/0167-5699(92)90091-K. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES